Clinical Trial Update: LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth) [Phase 3]

View source ↗

Summary

Phase 3 trial HepaGrowth is evaluating low molecular weight heparin for treatment of early fetal growth restriction and is currently enrolling by invitation; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Pre-eclampsia
• Premature Birth

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Centro Hospitalar de Lisboa Central | Conditions: Fetal Growth Retardation, Prematurity | Phase 3 | Status: ENROLLING_BY_INVITATION